SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under
the Securities Exchange Act of 1934
For the month of June, 2023
Commission File Number 001-39670
PURETECH HEALTH PLC
(Translation of registrants name into English)
6 Tide Street, Suite 400
Boston, Massachusetts 02210
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
The attached letters were delivered to shareholders of PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (the Company).
The press release is furnished herewith as Exhibit 99.1 and Exhibit 99.2 and is incorporated by reference herein.
99.1 Cover letter from the Company to its shareholders
99.2 Letter from KPMG to the shareholders of the Company
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|PURETECH HEALTH PLC|
Date: June 12, 2023
|Chief Executive Officer|
PureTech Health plc
6 Tide Street, Suite 400, Boston, MA 02210
Tel 617.482.2333 Fax 617.482.3337
This letter is being sent to the shareholders of PureTech Health plc (the Company) for information only and no action is required to be taken. If you have sold or transferred all of your ordinary shares in the Company you should pass this document to the purchaser or transferee or to the person through whom the sale was effected for transmission to the purchaser or transferee.
9 June 2023
CHANGE OF AUDITOR
As explained in this years Notice of Annual General Meeting, following a formal and comprehensive tender process, the Audit Committee recommended to the Board the appointment of PricewaterhouseCoopers LLP as the preferred new auditor. Based on this recommendation, the Board is proposing that PricewaterhouseCoopers LLP be appointed as external auditor of the Company pursuant to a resolution to be proposed at the Annual General Meeting that is due to be held on 13 June 2023.
KPMG LLP has consequently resigned as auditor of the Company effective from 31 May 2023. We are required by section 520(2) of the Companies Act 2006 to send a copy of KPMG LLPs resignation statement to shareholders. A copy of the statement is set out overleaf.
This letter needs no action on shareholders part but is provided to you in fulfilment of a statutory obligation upon the Company.
Director and Company Secretary
PureTech Health plc is a public limited company incorporated in England & Wales under company number 09582467. Registered office: 8th Floor, 20 Farringdon Street, London EC4A 4AB, United Kingdom.
15 Canada Square
London E14 SGL
Tel +44 (0) 20 7311 1000
Fax +44 (0) 20 7311 3311
Private & confidential
PureTech Health plc
20 Farringdon Street London
Our ref AR-1762
Contact Bob Seale
31 May 2023
Statement to PureTech Health plc (no. 09582467) on ceasing to hold office as auditors pursuant to section 519 of the Companies Act 2006
The reason connected with our ceasing to hold office is the holding of a competitive tender for the audit, in which we were unsuccessful in retaining the audit.
Audit registration number: 9188307
Audit registration address:
15 Canada Square
Canary Wharf, London E14 5GL
|KPMG LLP, a UK limited liability partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee.||Registered in England No OC301540 Registered office: 15 Canada Square, London, E14 5GL For full details of our professional regulation please refer to Regulatory information under About at www.kpmg.com/uk|
Reference - AR-1762
Document Classification KPMG Highly Confidential